Pfizer Q1 Profit Rises; Cuts Adj. EPS Outlook To Reflect Impact For Accounting Policy Change

Pfizer Inc. (PFE) reported a 76 percent year-over-year operational adjusted earnings per share growth in its first quarter. Also, the company recorded 82% operational revenue growth overall and 2% operational growth excluding Comirnaty and Paxlovid. The company said its revenue growth was primarily driven by Comirnaty, Paxlovid, Prevnar family in U.S., Eliquis, Vyndaqel and Oncology Biosimilars in U.S.

from RTT - Top Story https://ift.tt/focIAPb
via IFTTT